Please see below for a selection of interesting articles on pediatric CML in peer-reviewed journals.
Latest publications include:

• Outcome of pediatric chronic myeloid leukemia with management focusing on gene transcript levels
  Al-Ghamlas I et al. Int J Pediatr Adolesc Med, September 2022 – open access publication
  
• Dasatinib-related pleural effusion and lymphocytosis rates are different between adult and pediatric patients with Philadelphia chromosome-positive leukemias: are age and comorbidities only to blame?
  Kiliçaslan NA et al. Expert Rev Respir Med, September 2022 (epub ahead of print)
• Secondary pseudotumor cerebri syndrome in a child with chronic myeloid leukemia: Report of a case and review of previous cases
  Rasmussen AH et al. Pediatr Blood Cancer, September 2022 (epub ahead of print)
• Management of CML in children and young adults - Review
  Ford M et al. Curr Hematol Malig Res, August 2022 (epub ahead of print) - open access publication
• Discontinuation of tyrosine kinase inhibitors based on BCR-ABL1 monitoring by digital droplet PCR in pediatric chronic myeloid leukemia
  Kim Y et al. Front Pediatr, Jul 2022 – open access publication
• Ponatinib in pediatric patients with Philadelphina chromosome-positive leukemia: a retrospective survey of the Japan Children’s Cancer Group
  Kodama Y et al. Int J Hematol, July 2022
• Sensoineural hearing loss in juvenile CML: A Rare Case Report in Surabaya, Indonesia
  Syamsuddin IK and Notopuro PB. Int Med Case Rep J, July 2022 – open access publication
• Successful eradication of chronic myeloid leukemia in a child despite allogeneic graft rejection
  Vuorenoja S et al. Cancer Rep (Hoboken), July 2022 (epub ahead of print) – open access publication
• Outcome prediction of chronic myeloid leukemia (CML) in children
  Leung WY et al. Ann Hematol, June 2022 (epub ahead of print)
• Pediatric chronic myelogenous leukemia in T-lineage blast crisis: A reminder in relevance
  Patel SA and Beck JC. J Pediatr Hematol Oncol, April 2022
• Distribution and frequency of tyrosine kinase inhibitor-associated long-term complications in children with chronic myeloid leukemia
  Dong EE et al. Pediatr Blood Cancer, May 2022 (epub ahead of print)

Search here for more publications on pediatric CML